On a Mission to End Diabetes
Diabetes is the seventh-leading cause of death in the United States. The Diabetes Group at Sanford Research aims to fight this public health threat by researching type 1 and gestational diabetes.
We have a special interest in type 1 diabetes with The Sanford Project, an initiative to cure type 1 diabetes – the type that typically affects children.
We plan to end type 1 diabetes through discovery in three key areas:
- Autoimmunity: stopping the immune system’s attack on the body’s insulin-producing beta cells
- Prevention: identifying children at high risk and intervening before the onset of autoimmunity
- Regeneration: harnessing advancements in regenerative medicine to stimulate repair mechanisms and reboot insulin-producing beta cells
Our comprehensive strategy promises faster progress toward improving diabetes patients’ lives.
The Diabetes research group supports:
Primary Faculty
Secondary Faculty
Sanford Health News
-
background-image
Research nurses publish study on living through COVID-19
Rural RNs share impact of pandemic on work and home life in close-knit communities
-
background-image
Cardiologist from Poland visits U.S. to learn from Sanford
Dr. Pawel Buszman discusses population health, inherited heart disease, and early detection
Classes & Events
-
background-image
PROMISE Summer Camps
Tue 07/12/22 8:00 AM - Tue 07/12/22 4:00 PM
-
background-image
PROMISE Summer Camps
Fri 07/15/22 8:00 AM - Fri 07/15/22 4:00 PM
Sanford PROMISE Community Lab